Vol. 24.S1 September 2021 | Annals of Hepatology

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2021;24 Supl 1:100366

Full text access

Ann Hepatol. 2021;24 Supl 1:100533

Open access

P-1 PREVALENCE AND EPIDEMOLOGY OF BACTERIAL INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS: A RETROSPECTIVE STUDY OF PATIENTS ADMITTED AT THE SAN RAFAEL DE ALAHUELA HOSPITAL, COSTA RICA

Alejandra Ochoa, Pablo Coste, José Moreno

Ann Hepatol. 2021;24 Supl 1:100366.1

Open access

P-2 HEPATIC STEATOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN BRAZIL: PREVALENCE AND RISK FACTORS

Marina Ferri-Pezzini, Hugo Cheinquer, Alexandre de Araujo, Carlos T. Schmidt-Cerski, Eduardo Sprinz, Fernando Herz-Wolff, Julia Poeta

Ann Hepatol. 2021;24 Supl 1:100366.2

Open access

P-3 IMPACT OF THE SUSTAINED VIROLOGICAL RESPONSE ON THE GLUCOSE METABOLISM IN PATIENTS WITH HEPATITIS C

Fabia Benetti, Ítalo de Maman Júnior, Cristina Coelho Borges Cheinquer, Fernando Wolff, Alexandre de Araújo, Hugo Cheinquer

Ann Hepatol. 2021;24 Supl 1:100366.3

Open access

P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS

Martín Uriel Vázquez-Medina, Cesar Montejo-Velázquez, Cruz Vargas-De-León, Arcelia Carolina Barrón-Campos, José Antonio Almeyda-Farfán, Julián Gonzalo Gándara-Calderón, Claudia Pantaleón-Martínez, Nerina del Carmen Fernández-Martínez, ... Eira Cerda-Reyes

Ann Hepatol. 2021;24 Supl 1:100366.4

Open access

P-5 HEPATITIS E VIRUS INFECTION INCREASES THE RISK OF DIABETES AND MORTALITY IN HCV infected patients

Patricia Momoyo Yoshimura Zitelli, Michele Gomes-Gouvêa, Daniel F. Mazo, Julio da Motta Singer, Claudia PMS Oliveira, Alberto Queiroz Farias, João Renato Pinho, Ryan YukimatsuTanigawa, ... Mário Guimarães Pessoa

Ann Hepatol. 2021;24 Supl 1:100366.5

Open access

P-6 SOFOSBUVIR CONTAINING REGIMENS ARE SAFE AND EFFECTIVE IN ADOLESCENTS WITH CHRONIC HEPATITIS C INFECTION

Stefan Wirth, Regino Gonzalez-Peralta, Philip Rosenthal, Winita Hardikar, Jessica Wen, Maureen M. Jonas, Naveen Mittal, Mary Whitworth, ... William Balistreri

Ann Hepatol. 2021;24 Supl 1:100366.6

Open access

P-7 CLINICAL AND HISTOPATHOLOGICAL FEATURES OF THIRTY-FIVE OBLITERATIVE PORTAL VENOPATHY PATIENTS AND POTENTIAL ROLE OF XENOBIOTICS

Vinicius Santos Nunes, Gildasio Junior, Maria Isabel SchinoiI, Luis Freiras, Raymundo Prana

Ann Hepatol. 2021;24 Supl 1:100366.7

Open access

P-8 PRESERVATION OF THROMBIN GENERATION IN CIRRHOSIS DESPITE ABNORMAL RESULTS OF INTERNATIONAL NORMALIZED RATIO: IMPLICATIONS FOR INVASIVE PROCEDURES

Caroline Marcondes Ferreira, Tania Rubia Flores da Rocha, Evandro Oliveira Souza, Flair Jose Carrilho, Elbio Antonio D'amico, Alberto Queiroz Farias

Ann Hepatol. 2021;24 Supl 1:100366.8

Open access

P-9 SAFETY AND EFFECTIVENESS OF DIRECT ACTING AGENTS FOR HCV TREATMENT AFTER LIVER TRANSPLANTATION IN RIO DE JANEIRO (BRAZIL)

L.C.M. Pinto, E. Balbi, Halpern, L.P. Carius, J. Roma, L.F.P. Moreira, H. Perazzo

Ann Hepatol. 2021;24 Supl 1:100366.9

Open access

P-10 LATIN AMERICAN REGISTRY OF CHOLANGIOCARCINOMA: CLINICAL FEATURES, MANAGEMENT AND OUTCOMES

Leonardo G. da Fonseca, Laura Izquierdo-Sanchez, Pedro H. Hashizume, Estefanía Liza Beca, Yanina Carlino, Enrique Carrera, Marco Arrese, Javier Díaz Ferrer, ... Jesus M. Banales

Ann Hepatol. 2021;24 Supl 1:100366.10

Open access

P-11 POTENTIALLY HEPATOTOXIC DRUGS ARE STILL BEING PRESCRIBED TO LIVER DISEASE PATIENTS UNDER TERTIARY CARE: IT IS TIME TO SAY ENOUGH

Rodrigo Dorelo, Samantha T.A. Barcelos, Magela Barros, Valeria Elustondo, Ysela Y.P. Pérez, Martin Oricchio, Nelson D.S. Uribe, Nelia Hernandez, ... Mário R. Álvares-da-Silva

Ann Hepatol. 2021;24 Supl 1:100366.11

Open access

P-12 QUALITATIVE EVALUATION OF NATURAL PRODUCTS USED BY PATIENTS IN A BRAZILIAN HEPATOTOXICITY AMBULATORY

Caio Medina Lopes, Andréia de Santana Souza, Ademir do Vale, Juceni Pereira David, Genario Santos, Vinicius Santos Nunes, Maria Isabel Schinoni, Raymundo Paraná

Ann Hepatol. 2021;24 Supl 1:100366.12

Open access

P-13 COMPARISON OFF DIFFERENT PROGNOSTIC SCORES FOR PATIENTS WITH CIRRHOSIS HOSPITALIZED WITH SARS – COV 2 INFECTION

Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, Aldo Torre, Pedro Montes, ... Marcelo O. Silva

Ann Hepatol. 2021;24 Supl 1:100366.13

Open access

P-14 EVALUATION AND SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION: AN ECONOMIC PERSPECTIVE. RETROSPECTIVE STUDY

Santiago Rodríguez, Fabio Da Motta, Giacomo Balbinoto Neto, Ajacio Brandão

Ann Hepatol. 2021;24 Supl 1:100366.14

Open access

P-15 WAITING LIST FOR LIVER TRANSPLANTATIOS: CLINICAL AND ECONOMIC BURDEN, RETROSPECTIVE STUDY

Santiago Rodríguez, Fabio Da Motta, Giacomo Balbinoto Neto, Ajacio Brandão

Ann Hepatol. 2021;24 Supl 1:100366.15

Open access

P-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO

José Alfredo Salinas-Casanova, Daniel Almaguer-Morales, Salvador Bruno Valdovinos-Chávez, Luis Alonso Morales-Garza, María Teresa Sánchez-Ávila, Juan Francisco Sánchez-Ávila

Ann Hepatol. 2021;24 Supl 1:100366.16

Open access

P-19 ANTI-RIBOSOMAL P (ANTI-P) ANTIBODIES IN AUTOIMMUNE HEPATITIS PATIENTS

Clarisse de Almeida Gallo, Alessandra Delavance, Antônio Eduardo Silva, Luis Eduardo Andrad, Ivonete Silva, Maria Lúcia Ferraz

Ann Hepatol. 2021;24 Supl 1:100366.17

Open access

P-20 METABOLIC ASSOCIATED FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES

Priscila Pollo Flores, Débora Vieira Soares, Maria Auxiliadora Saad, Clara Petrucio, Wallison Rodrigues Gonçalves, Caio Oliveira Menezes, Gabriella Mundim, Gabriella Santos, ... Gabriela Muller Machado

Ann Hepatol. 2021;24 Supl 1:100366.18

Open access

P-21 BONE MASS, VITAMIN D LEVELS AND NONALCOHOLIC FATTY FIVER DISEASE

Clara Petrucio, Wallison Rodrigues Gonçalves, Caio Oliveira Menezes, Gabriel Alverca Meyas, Vanessa da Costa Rodrigues, Flavio Marques de Oliveira Filho, Maria Auxiliadora Saad, Priscila Pollo Flores, Débora Vieira Soares

Ann Hepatol. 2021;24 Supl 1:100366.19

Open access

P-22 ANALYSIS OF FEATURES ASSOCIATED WITH DIFFICULTY IN SCREENING AND EARLY DIAGNOSING HEPATOCELLULAR CARCINOMA IN RISK PATIENTS

João Eugênio Loureiro Lopes, Júlia Antunes RizzoBicalho, Livia Zardo Trindade, Mariana Poltronieri Pacheco

Ann Hepatol. 2021;24 Supl 1:100366.20

Open access

P-23 SEROLOGICAL PROFILE OF HEPATITIS B AND C IN REUMATHOLOGIC PATIENTS IN USE OF IMMUNOSSUPRESSIVE THERAPY

Gabriela Azevedo Solino, Camilla Bortolini Chamoun, Victoria Caroline Danielle Da Silva, Valquíria Garcia Dinis, Mariana Poltronieri Pacheco

Ann Hepatol. 2021;24 Supl 1:100366.21

Open access

P-24 FREQUENCY AND SEVERITY OF LIVER INVOLVEMENT IN PREGNANT WOMEN ADMITTED TO AN INTENSIVE CARE UNIT WITH HYPERTENSIVE DISORDERS OF PREGNANCY

J. Castro, M. De Lucca, L. Codes, M.A. Soares, L. Lyrio, P. Bittencourt

Ann Hepatol. 2021;24 Supl 1:100366.22

Open access

P-25 SLOWER FIBROSIS PROGRESSION IN HEPATITIS C HEMOPHILIAC PATIENTS?

Dauana O. Bastos, Christini Emori, Sandra V. Antunes, Flavia Appel, Maria Lucia Ferraz

Ann Hepatol. 2021;24 Supl 1:100366.23

Open access

P-26 PORTAL VENOUS THROMBOSIS IN TRANSPLANTED CIRRHOTIC PATIENTS AT THE “HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE”

V.N. Henríquez Auba, F. Ramirez, M. Fabres, P. Abarca, B. Astrosa, D. Vera, J.C. Diaz, J. Castillo, ... A. Urzua

Ann Hepatol. 2021;24 Supl 1:100366.24

Open access

P-27 ALTERATION IN LIVER FUNCTION TESTS AMONG PATIENTS HOSPITALIZED FOR COVID-19: A MULTICENTRIC STUDY IN PERU

Ivania Marín Dueñas, Jenny Vega, Hugo Carrillo-Ng, Isabel Veramendi-Schult, Ricardo Zavaleta Alva, Luis Vásquez, Zeneida Gonzales-Soler, Hellen Agurto-Lescano, ... Adelina Lozano

Ann Hepatol. 2021;24 Supl 1:100366.25

Open access

P-28 BODY COMPOSITION MEASUREMENT AND NONALCOHOLIC FATTY LIVER DISEASE

Maria Auxiliadora Nogueira Saad, Débora Vieira Soares, Priscila Pollo Flores, Rosa Leonora Salerno Soares, Vinicius César Jardim Pereira, Maria Clara Brito Pontes

Ann Hepatol. 2021;24 Supl 1:100366.26

Open access

P-29 CLINICAL FEATURES OF PRIMARY BILIARY CHOLANGITIS IN BRAZIL

Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria, ... members of the Brazilian Cholestasis Study Group Consortium

Ann Hepatol. 2021;24 Supl 1:100366.27

Open access

P-30 IMPACT OF PUBLIC HEALTH POLICIES ON ALCOHOL-ASSOCIATED LIVER DISEASE IN LATIN AMERICA: AN ECOLOGICAL MULTI-NATIONAL STUDY

Antonio Díaz Luis, Francisco Idalsoaga, Eduardo Fuentes-López, Andrea Márquez, Carolina A. Ramírez, Juan Pablo Roblero, Araujo Roberta C., Fátima Higuera – de – la – tijera, ... Juan Pablo Arab

Ann Hepatol. 2021;24 Supl 1:100366.28

Open access

P-31 NORMAL TRANSAMINASES IN OBESE PATIENTS WITH METABOLIC ASSOCIATED STEATOHEPATITIS

Adelina Lozano, Hugo Carrillo-Ng, Cesar Castro, Zenaida Lozano, Lil Saavedra, Gustavo Salinas

Ann Hepatol. 2021;24 Supl 1:100366.29

Open access

P-32 EVALUATION OF HEPATIC FIBROSIS THROUGH NON-INVASIVE METHODS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C

Felipe José de Oliveira Fraga, Leila Maria Soares Tojal de Barros Lima

Ann Hepatol. 2021;24 Supl 1:100366.30

Open access

P-33 EVALUATION OF CIRCULATING METABOLOME IN THE SEARCH OF POTENTIAL DRUG-INDUCED LIVER INJURY BIOMARKERS

Daniel E. Di Zeo-Sánchez, Inmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Miren Garcia-Cortes, Aida Ortega-Alonso, Alejandro Cueto-Sanchez, Rocio San Juan-Jimenez, Andrés Gonzalez-Jimenez, ... Mercedes Robles-Diaz

Ann Hepatol. 2021;24 Supl 1:100366.31

Open access

P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY

S. Blanco-Sampascual, I. Gorostiza-Hormaetxe, F. Menéndez-Blázquez, P. Ruiz-Eguiluz, A. Baranda-Martín, A. Castrillo-Olabarria, M.A. Gómez-Suárez, A. Calderón-García

Ann Hepatol. 2021;24 Supl 1:100366.32

Open access

P-35 NONINVASIVE PREDICTORS OF ESOPHAGEAL VARICES IN PATIENTS WITH HEPATOSPLENIC SCHISTOSOMIASIS MANSONI: MULTICENTER STUDY

Mateus Jorge Nardelli, Zulane da Silva Tavares Veiga, Luciana Costa Faria, Gustavo Henrique Santos Pereira, Catherine Ferreira da Silva, Fernanda Aziz Barbosa, Flávia Ferreira Fernandes, Renata de Mello Perez, ... Claudia Alves Couto

Ann Hepatol. 2021;24 Supl 1:100366.33

Open access

P-36 ACCURACY OF PROGNOSTIC SCORES IN PREDICTION OF MORTALITY IN CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Pedro Silva, Fernanda Rios, Liana Codes, Carolina Esteve, Murilo Filho, Douglas Lima, Geraldo Filho, Bruno Lima, ... Paulo Bittencourt

Ann Hepatol. 2021;24 Supl 1:100366.34

Open access

P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C

J.L. Pérez Hernández, Aldo Torre Delgadillo, Graciela Castro Narro, Eira Cerda Reyes, Mayra Virginia Ramos Gómez, Leonardo Juárez Chávezx, Margarita Dehesa Violante, Linda Muñoz Espinosa, ... María de Fátima Higuera de la Tijera

Ann Hepatol. 2021;24 Supl 1:100366.35

Open access

P-38 UTILITY OF PUPILLARY REACTIVITY IN THE FUNCTIONAL ASSESSMENT OF THE AUTONOMOUS NERVOUS SYSTEM IN PATIENTS WITH CHRONIC LIVER DISEASE: PRELIMINARY RESULTS

Christian Lara, Abraham Gajardo, Flavia Giubergia, Nicolás Bustos, Juan Pablo Roblero, Alvaro Urzúa, Jaime Poniachik, Máximo Cattaneo

Ann Hepatol. 2021;24 Supl 1:100366.36

Open access

P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY

Claudia Muñoz, Felipe Ramírez, Nicolás Martínez, Patricio Palavecino, Claudia Pavez, Alvaro Urzúa, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poníachik

Ann Hepatol. 2021;24 Supl 1:100366.37

Open access

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION

Andrea Jiménez, Alan Poniachik, Eladio González, Andrés De la Vega, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik, Alvaro Urzúa

Ann Hepatol. 2021;24 Supl 1:100366.38

Open access

P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE

Juan Pablo Roblero, Juan Pablo Arab, Christian Von Muhlenbrock, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.39

Open access

P-42 SEROPREVALENCE OF IgG and IgM ANTI-HEV ANTIBODIES USING AN AUTOMATED METHOD: EXPERIENCE OF A UNIVERSITY CENTER

Natalia Covarrubias, Constanza Bohle, Christian Lara, Julio Miranda, Carmen Hurtado, Mauricio Venegas

Ann Hepatol. 2021;24 Supl 1:100366.40

Open access

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA

Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Javier Ortiz, Patricio Palavecino, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.41

Open access

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION

Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.42

Open access

P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR

Alvaro Urzúa, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.43

Open access

P-46 EPIDEMIOLOGICAL PROFILE AND CLINICAL OUTCOMES OF PATIENTS INTOXICATED WITH ACETAMINOPHEN FOR SUICIDAL PURPOSES AT HOSPITAL SAN VICENTE FUNDACIÓN RIONEGRO: A CASE SERIES

Daniel Vasquez, Luis Guillermo Toro, Marle Duque, Lina María Ramiréz, Luisa Fernanda Ahunca, Diana Restrepo

Ann Hepatol. 2021;24 Supl 1:100366.44

Open access

P-47 HISTOPATHOLOGICAL ANALYSIS OF 10-YEAR PROTOCOL LIVER ALLOGRAFT BIOPSY OF ASYMPTOMATIC PEDIATRIC RECIPIENTS FROM A SINGLE BRAZILIAN CENTER

Luciana E. Soares, Carlos Thadeu Carski, Carlos O. Kieling, Marina Adami, Renata Rostirola Guedes, Ariane Backes, Ian Leipnitz, Sandra M.G. Vieira

Ann Hepatol. 2021;24 Supl 1:100366.45

Open access

P-48 HEPATITIS DELTA: THE MOST SEVERE OF ALL VIRAL HEPATITIS

Júlia Teixeira Ton, Ester Teixeira Ton, Alcione de Oliveira dos Santos, Juan Miguel Villalobos Salcedo, Deusilene Vieira Dallácqua, Mariana Pinheiro Alves Vasconcelos

Ann Hepatol. 2021;24 Supl 1:100366.46

Open access

P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW

Priscila Pollo-Flores, Gabriel Alverca Meyas, Vanessa Rodrigues, Janaisa Moraes de Souza, Pamela Moura Rodrigues Cardoso, Iasmin Torres Leitão, Stephanie Cathren Fenizola dos Santos da Silva, Lívia Melo Villar

Ann Hepatol. 2021;24 Supl 1:100366.47

Open access

P-50 PREVALENCE OF HEPATITIS AMONG STUDENTS AND HEALTH PROFESSIONALS AT THE FEDERAL UNIVERSITY OF BAHIA

Jacy Andrade, Lucas Sousa Macêdo, Fernanda Bastos, Marco Antônio Vasconcelos Rêgo, Robert Eduard Schaer, Roberto Meyer, Juçara Magalhães Simões, Songeli Menezes Freire, ... Maria Isabel Schinoni

Ann Hepatol. 2021;24 Supl 1:100366.48

Open access

P-51 HEPATOCELLULAR CARCINOMA: ONLY EARLY DIAGNOSIS IS NOT ENOUGH

Fernanda Soares Gomes Canedo, Monica Klimczuk Fernandes, Maria Lucia Pedroso

Ann Hepatol. 2021;24 Supl 1:100366.49

Open access

P-52 PROSPECTIVE COHORT OF PATIENTS WITH LIVER INJURY INDUCED BY DRUGS, HERBS OR DIETARY SUPPLEMENTS

Vinícius Santos Nunes, Catarina Secundino, Luísa Latado, Genário Santos, Raimundo Paraná, Maria Isabel Schinoni

Ann Hepatol. 2021;24 Supl 1:100366.50

Open access

P-53 FAILURE IN ALL STEPS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE PROCESS IS FREQUENT IN DAILY PRACTICE.

Melisa Dirchwolf, Sebastián Marciano, Andres E. Ruf, Amit G. Singal, Vanina D'Ercole, Paola Coisson, Alina Zerega, Federico Orozco, ... Gisela Gualano

Ann Hepatol. 2021;24 Supl 1:100366.51

Open access

P-54 STUDY OF BACTERIAL INFECTIONS IN 134 HOSPITALIZATIONS OF PATIENTS WITH LIVER CIRRHOSIS

Rodrigo Fedatto Beraldo, Maria Clara Vidal Regueiro, Thaís Gagno Grillo, Maria Natália Marques dos Santos, Mariana Barros Marcondes, Luciana Almeida Rocha, Giovanni Faria Silva

Ann Hepatol. 2021;24 Supl 1:100366.52

Open access

P-55 QUALITY OF LIFE IMPROVES IN PATIENTS WITH OR WITHOUT CIRRHOSIS AFTER HEPATITIS C CURE WITH DIRECT-ACTING ANTIVIRAL AGENTS

Lucrecia Garcia Olveira, Sebastián Marciano, Leila Haddad, Monica Fabiola Vasquez Palacios, Diego Giunta, Adrian Gadano

Ann Hepatol. 2021;24 Supl 1:100366.53

Open access

P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS

Aline Lamaison, Javier Troncoso, Pablo Villafranca, Marcel Bonilla, Maximo Cattaneo, Laura Carreño, Jaime Poniachik, Alvaro Urzúa

Ann Hepatol. 2021;24 Supl 1:100366.54

Open access

P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER

Ana Jiménez, Felipe Contreras, Miguel Leiva José, Nicolás Moreno, Claudio Altschiller, Andrea Jimenez, Alvaro Urzúa, Maximo Cattaneo, ... Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.55

Open access

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

Juan Francisco Rozas, Katherine González, Camila Estay, Maximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Alexandra Sandoval, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.56

Open access

P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE

Hiru Chang, Danett Guiñez, Juan Francisco Rozas, Fodda Chelech, Víctor Henríquez, Alvaro Urzúa, Maximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.57

Open access

P-61 LIVER TRANSPLANTATION IN HEPATOCARCINOMA: SURVIVAL AND RECURRENCE IN TRANSPLANTED PATIENTS WITH HEPATOCARCINOMA

Daniela García, Fodda Chelech, Andrea Jiménez, Alvaro Urzúa, Maximo Cattaneo, Juan Pablo Roblero, Alexis Iracheta, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.58

Open access

P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE

Gabriel Uribe, Alvaro Urzua, Maximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.59

Open access

P-63 TRENDS IN HOSPITALIZATION AND MORTALITY IN HOSPITALIZED PATIENTS WITH ALCOHOLIC HEPATITIS IN CHILE

Juan Pablo Roblero, Juan Pablo Arab, Christian Von Muhlenbrock, Alejandra Dominguez, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.60

Open access

P-64 THE ALCOHOL-ASSOCIATED LIVER DISEASE PARADOX IN CHILE: AN ASSESSMENT WITH DATA FROM THE NATIONAL HEALTH SURVEY (ENS 2016-2017)

Gianfranco Oneto, Luis Antonio Díaz, Francisco Idalsoaga, Juan Pablo Arab, Pablo Roblero, Maximo Cattaneo, Alvaro Urzua, Jaime Poniachik, Juan Pablo Roblero

Ann Hepatol. 2021;24 Supl 1:100366.61

Open access

P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS

Juan Francisco Rozas, Katherine González, Camila Estay, Maximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Alexandra Sandoval, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.62

Open access

P-66 COULD PROTEIN CONTENT OF URINARY EXTRACELLULAR VESICLES BE USEFUL TO DETECT CIRRHOSIS IN ALCOHOLIC LIVER DISEASE?

E. Gonzalez, M. Azkargorta, C. Garcia-Vallicrosa, J. Prieto-Elordui, F. Elortza, S. Blanco-Sampascual, J.M. Falcon-Perez

Ann Hepatol. 2021;24 Supl 1:100366.63

Open access

P-67 ULTRASOUND GUIDED TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS AND STAGING OF LIVER FIBROSIS

Juan Francisco Rozas, Katherine González, Luis Salazar, Máximo Cattaneo, Juan Pablo Roblero, Alvaro Urzúa, Alexandra Sandoval, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.64

Open access

P-68 FREQUENCY AND FACTORS ASSOCIATED WITH ANTIBIOTIC DE-ESCALATION IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS

Maria Nelly Gutierrez Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, Jose Luis Fernandez, Silvina Tevez, Maria Margarita Anders, Nadia Grigera, ... Sebastián Marciano

Ann Hepatol. 2021;24 Supl 1:100366.65

Open access

P-69 RELATION BETWEEN CLINICAL AND ELASTOGRAPHIC CHARACTERISTICS OF CIRRHOTIC PATIENTS WITH ENDOSCOPIC VARICEAL LIGATION: A SINGLE-CENTER EXPERIENCE IN LIMA, PERU

Jorge Garavito-Rentería, Rommel Zambrano-Huailla, William J. Araujo-Banchon

Ann Hepatol. 2021;24 Supl 1:100366.66

Open access

P-70 SEROPREVALENCE OF HEPATITIS C VIRUS IN DONORS OF THE BLOOD BANK OF THE GENERAL HOSPITAL OF MEXICO "DR. EDUARDO LICEAGA " A FOUR-YEAR EVALUATION

José Luis Pérez Hernández, María Virginia Murcia Sandoval, Alejandro Bonilla Ramos, Carlos Andrés Campoverde Espinoza, Yadira Lilian Béjar Ramírez, María de Fátima Higuera de la Tijera

Ann Hepatol. 2021;24 Supl 1:100366.67

Open access

P-71 EVALUATION OF ANXIETY AND DEPRESSION IN PATIENTS WITH CIRRHOSIS AND THE IMPACT ON THE QUALITY OF LIFE

Pérez Hernández José Luis, Flores Torres Andrea, Lopez Pérez Raquel Yazmin, Soto Hernández Karla Andrea, Higuera de la Tijera Maria de Fátima

Ann Hepatol. 2021;24 Supl 1:100366.68

Open access

P-72 CLINICAL PROFILE OF PATIENTS SUBJECTED TO ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICES IN A REFERENCE HOSPITAL IN THE DOMINICAN REPUBLIC

Mateo Duran Aileen, Sanchez Fabiolina

Ann Hepatol. 2021;24 Supl 1:100366.69

Open access

P-73 HEPATIC CHANGES BY SARS-COV 2 IN PATIENTS OF THE INTENSIVE CARE UNIT OF THE TROPICAL MEDICINE CENTER IN RONDÔNIA

Camylla Felix Soares, Júlia Teixeira Ton, Luana Kamila Castilho Rodrigues, Stella Ângelo Zimmerli, Mariana Pinheiro Alves Vasconcelos

Ann Hepatol. 2021;24 Supl 1:100366.70

Open access

P-74 ELEVATED CALPROTECTIN LEVELS ARE ASSOCIATED WITH MORTALITY IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS

Camila Matiollo, Elayne Cristina de Moraes Rateke, Emerita Quintina de Andrade Moura, Michelle Andrigueti, Fernanda Cristina De Augustinho, Tamara Liana Zocche, Telma Erotides da Silva, Lenyta Oliveira Gomes, ... Leonardo de Lucca Schiavon

Ann Hepatol. 2021;24 Supl 1:100366.71

Open access

P-75 UPDATE OF CLINICO-EPIDEMIOLOGICAL CHARACTERISTICS OF PRIMARY BILIAR CHOLANGITIS IN URUGUAY

Etchandy Patricia, Chiodi Daniela, Veloso Victoria, Hernandez Nelia

Ann Hepatol. 2021;24 Supl 1:100366.72

Open access

P-76 PROGNOSTIC FACTORS FOR SEVERITY AND MORTALITY IN COVID-19: ARE LIVER TESTS IMPORTANT?

Fernanda Manhaes Pozzobon, Perez Renata Mello, Henrique Custódio Goudar, Anna Butter Nunes, Maria Chiara Chindamo

Ann Hepatol. 2021;24 Supl 1:100366.73

Open access

P-77 PREVALENCE OF HCV INFECTION DETECTED BY RAPID ANTIBODY TEST IN SCREENING CAMPAIGNS IN LIMA AND CALLAO – PERU

Javier Diaz Ferrer, Pedro Montes Teves, Vanessa Valenzuela Granados, Kriss Rodríguez Romero, Rocío Galloso Gentille, Rocío Ramos Miraval

Ann Hepatol. 2021;24 Supl 1:100366.74

Open access

P-78 USE OF ARTERIAL CONDUITS IN LIVER TRANSPLANTATION: OUTCOMES IN A SINGLE CENTRE IN PERU

Alfonso Solar Peche, Wilmer Bacilio Calderon, Carlos Rondon Leyva, Omar Mantilla Cruzatti, José Rivera Romani, Bertha Cardenas Ramirez, Carmen Cerron Cabezas, Augudberto Montufar Valer, ... P. Martin Padilla Machaca

Ann Hepatol. 2021;24 Supl 1:100366.75

Open access

P-79 CHOOSING WISELY IN VIRAL HEPATITIS: RECOMMENDATIONS FROM THE BRAZILIAN SOCIETY OF HEPATOLOGY

Cristiane A. Villela-Nogueira, Maria Lúcia Gomes Ferraz, Mário Guimarães Pessoa, Francisco José Dutra Souto, Letícia Cancella Nabuco, Henrique Sérgio Moraes Coelho, Paulo Lisboa Bittencourt, Carlos Eduardo Brandão-Mello

Ann Hepatol. 2021;24 Supl 1:100366.76

Open access

P-80 SEVERELY OBESE PATIENTS HAD HEPATIC FIBROSIS EVEN WITHOUT METABOLIC SYNDROME

Carla Daltro, Ana Paula Berbeth-Casto, Luiz Antonio R de-Freitas, Antônio Ricardo Andrade, Helma P. Cotrim

Ann Hepatol. 2021;24 Supl 1:100366.77

Open access

P-81 ALTERNATIVE THERAPIES FOR DIFFICULT-TO-TREAT AUTOIMMUNE HEPATITIS: AN EXPERIENCE OF THREE BRAZILIAN REFERRAL CENTERS

Ana Julia Cardozo, Nayana Van Drummond, Amanda Longo, Eduardo Cancado, Claudia Couto, Luciana Faria, Gustavo Borgongino, Vivian Rotman, Andreia Evangelista

Ann Hepatol. 2021;24 Supl 1:100366.78

Open access

P-82 URSODEOXYCHOLIC ACID AND/OR CIPROFIBRATE FOR TREATING PATIENTS WITH PRESUMPTIVE DIAGNOSIS OF LOW PHOSPHOLIPID CHOLELITHIASIS, A CLINICAL SPECTRUM OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3

Fernanda Linahres, Debora Terrabuio, Michelle Braga, Laura Guedes, Flair Jose Carrilho, Eduardo Cancado

Ann Hepatol. 2021;24 Supl 1:100366.79

Open access

P-83 RELEVANCE OF RENAL CHANGES IN A LARGE SERIES OF SEVERELY OBESE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE

Kellyane Dias Carvalho, Carla Daltro, Claudia Daltro, Helma P. Cotrim

Ann Hepatol. 2021;24 Supl 1:100366.80

Open access

P-84 IMPLEMENTATION OF A STEP-BY-STEP STRATEGY BASED ON THE TREATMENT CASCADE TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS FROM URUGUAY. PRELIMINARY REPORT

Juan Otegui, Victoria Mainardi, Daniela Olivari, Ana Fernández, Carolina Ferreira, Solange Gerona

Ann Hepatol. 2021;24 Supl 1:100366.81

Open access

P-85 USE OF LOW DOSES OF GENERIC TACROLIMUS AND THERAPEUTIC LEVELS IN LIVER TRANSPLANT PATIENTS: RESULTS FROM A SINGLE CENTER IN PERU

P. Martín Padilla-Machaca, Cristopher Dávila, Bertha Cárdenas, Carmen Cerrón, Alberto Mantilla, José Rivera, Alfonso Solar, Augudberto Montufar, ... Carlos Rondón

Ann Hepatol. 2021;24 Supl 1:100366.82

Open access

P-86 MELD SCORE AND EARLY EXTUBATION IN THE INTENSIVE CARE UNIT AFTER LIVER TRANSPLANTATION: 20 YEARS EXPERIENCE IN A SINGLE CENTER IN PERU

Carmen Cerron, Rosa Lopez, Gino Salcedo, Bertha Cardenas, Carlos Rondon, Omar Mantilla, Jose Rivera, Alfonso Solar, ... Martin Padilla P.

Ann Hepatol. 2021;24 Supl 1:100366.83

Open access

P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL

Alanna Calheiros Santos, Vanessa Salete de Paula, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Laura Cristina Machado Pinto, Lia Laura Lewis-Ximenez, Livia Melo Villar

Ann Hepatol. 2021;24 Supl 1:100366.84

Open access

P-88 EVALUATION OF STEATOSIS AND LIVER FIBROSIS IN PATIENTS WITH PSORIASIS: THE IMPACT OF METHOTREXATE AND METABOLIC FACTORS ON THE SEVERITY OF THE DISEASE

Luciana Agoglia, Ana Carolina Cardoso, Nathalie Leite C., Maria Chiara Chindamo, Cristiane A. Villela-Nogueira

Ann Hepatol. 2021;24 Supl 1:100366.85

Open access

P-89 ASSESSMENT OF HEPATIC FIBROSIS IN TYPE 2 DIABETIC PATIENTS: A CROSS SECTIONAL ANALYSIS

Mincis Rodrigo, Altikes Renato Gama, Vanni Denise Siqueira, Rossi Da Maria Elizabeth, Zitteli Patrícia Momoyo, Carrilho Flair José, P. Oliveira Claudia, Pessoa Mario Guimarães

Ann Hepatol. 2021;24 Supl 1:100366.86

Open access

P-91 PREVALENCE OF HEPATITIS C VIRUS INFECTION DETECTED BY RAPID TEST IN A HIGH-RISK POPULATION

Pedro Montes Teves, Briny Rodriguez Vargas, Jaime Fustamante Flores, Eduardo Monge Salgado

Ann Hepatol. 2021;24 Supl 1:100366.88

Open access

P-93 PREVALENCE OF HEPATITIS E VIRUS IN DIFFERENT GROUPS OF PATIENTS IN SALVADOR, BA, BRAZIL

G. Lopes, C. Correia, D. Almeida, S. Cunha, S. Pacheco, V. Nunes, J. Cotinguiba, D. Lima, ... M.I. Schinoni

Ann Hepatol. 2021;24 Supl 1:100366.89

Open access

P-94 METABOLIC SYNDROME IN PATIENTS WITH CHRONIC HEPATITIS C

G.B.L. Menezes, C. Correia, M.I. Schinoni

Ann Hepatol. 2021;24 Supl 1:100366.90

Open access

P-95 HEPATOXICITY FOR DRUGS AND HERBAL PRODUCTS IN INPATIENTS FROM A UNIVERSITY HOSPITAL, BRAZIL

Barbosa Mariana Paranhos, Nunes Vinicius, Santos Genário, Paraná Raymundo, Schinoni Maria Isabel

Ann Hepatol. 2021;24 Supl 1:100366.91

Open access

P-97 COLOMBIAN EXPERIENCE IN THE MANAGEMENT OF PATIENTS WITH SARS-CoV-2 INFECTION AND LIVER TRANSPLANTATION

Andres Gomez Aldana, Monica Tapias, Jose De la Hoz, Juanita Leon, Katherine Marrugo, Jannet Lopez, Alvaro Lozada, Diego Roselli

Ann Hepatol. 2021;24 Supl 1:100366.92

Open access

P-98 BIOCHEMICAL MAKERS AMONG CHRONIC LIVER DISEASE PATIENTS ACCORDING COVID-19 INFECTION: A FOLLOW-UP STUDY

Lucas Lima da Silva, Alanna Calheiros Santos, Fabiola Justina Fumero Leon, Vanessa Duarte da Costa, Juliana Custódio Miguel, Julia Trece Marques, Giselle Prado do Nascimento, Elisangela Ferreira da Silva, ... Livia Melo Villar

Ann Hepatol. 2021;24 Supl 1:100366.93

Open access

P-99 PREVALENCE OF SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS. A CROSS-SECTIONAL STUDY AT TEODORO MALDONADO CARBO HOSPITAL

Zoila Teran, Denisse Marriott, Sammy Yepez, Emilia Vera, Eduardo Marriott

Ann Hepatol. 2021;24 Supl 1:100366.94

Open access

P-101 IMPACT OF COMPLETE AND PREVENTIVE LOCKED–DOWN BEFORE COVID 19 OUTBREAK IN ORGAN PROCUREMENT AND SOLID TRANSPLANTATION IN ARGENTINA: THE WORST HAS NOT YET ARRIVED.

Josefina Pages, Federico Piñero, Margarita Anders, Marcos Thompson, Ariel Gonzalez Campaña, Manuel Mendizabal, Martín Fauda, Florencia Antinucci, ... Marcelo Silva

Ann Hepatol. 2021;24 Supl 1:100366.95

Open access

P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION

Carolina Salinas, Katherine Marrugo, Martin Garzón, Leonardo Perez, Oscar Beltran, Geovanny Hernandez, Islena Blanco, Jairo Rivera, ... Gilberto Mejia

Ann Hepatol. 2021;24 Supl 1:100366.96

Open access

P-103 CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA ANALYSIS OF A TERTIARY REFERRAL CENTER IN BRAZIL

M.K. Yuami, A.M.F. Andrade, R. Teixeira, C.R.D. Carmo, L.Q. Santos, J.F. Castro, C.X. Lima

Ann Hepatol. 2021;24 Supl 1:100366.97

Open access

P-104 IMPACT OF BACTERIAL INFECTIONS IN THE CLINICAL COURSE OF CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Rac D'Oliveira, L. Codes, C.C. Zollinger, M.S. Rocha, P.L. Bittencourt

Ann Hepatol. 2021;24 Supl 1:100366.98

Open access

P-105 PREVALENCE OF ANTIMITOCHONDRIAL ANTIBODIES IN PATIENTS WITH PRIMARY BILE CHOLANGITIS AND ITS OUTCOME IN LIVER TRANSPLANTATION

Andres Gomez Aldana, Monica Tapias, Jose De la Hoz, Juanita Leon, Jannet Lopez, Alvaro Lozada

Ann Hepatol. 2021;24 Supl 1:100366.99

Open access

P-106 COVID-19 PRESENTATION AND OUTCOMES IN 33 PATIENTS WITH AUTOIMMUNE HEPATITIS

Julia Fadini Margon, Monique Raddatz Reis Vilela, Bruna Damasio Moutinho, Sabrina Rodrigues de Figueiredo, Marta Mitiko Deguti, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado

Ann Hepatol. 2021;24 Supl 1:100366.100

Open access

P-107 EPIDEMIOLOGICAL AND CLINICAL PROFILE OF AUTOIMMUNE HEPATITIS IN A BRAZILIAN TERTIARY HOSPITAL

Camila Toledo Turano, Renata da Silva Moutinho, Raul Carlos Wahle, Luiza Alencar Saldanha Queiroz, Claudia de Fatima Gomes Vieira Oliveira, Ana Luisa Vieira Rodrigues De Queiroz, Dora Gama Ribeiro Leite Altikes, Paula Bechara Poletti

Ann Hepatol. 2021;24 Supl 1:100366.101

Open access

P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA

Margarita Gutiérrez, Leonardo Pérez, Oscar Beltrán, Martín Garzón, Alejandra Amaya, Carolina Salinas, Geovanny Hernández, Cristina Torres, ... Adriana Varón

Ann Hepatol. 2021;24 Supl 1:100366.102

Open access

109 TREATMENT PROFILE OF AUTOIMMUNE HEPATITIS IN A BRAZILIAN TERTIARY HOSPITAL

Camila Toledo Turano, Renata da Silva Moutinho, Raul Carlos Wahle, Luiza Alencar Saldanha Queiroz, Claudia de Fatima Gomes Vieira Oliveira, Ana Luisa Vieira Rodrigues De Queiroz, Dora Gama Ribeiro LeiteAltikes, Paula Bechara Poletti

Ann Hepatol. 2021;24 Supl 1:100366.103

Open access

P-110 POST-TRANSPLANT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO DOWN-STAGING – BRAZILIAN MULTICENTER STUDY

Julia Fadini Margon, Aline Lopes Chagas, Angelo A. Mattos, Márcio Augusto Diniz, Guilherme Eduardo Gonçalves Felga, Ilka de Fátima Santana Ferreira Boin, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, ... Brazilian HCC Study Group

Ann Hepatol. 2021;24 Supl 1:100366.104

Open access

P-111 FREQUENCY OF LIVER STEATOSIS AND FIBROSIS DETERMINED BY FIBROSCAN AND CAP IN A SCREENING PROGRAM

Pedro Montes Teves, Rocío Galloso Gentille, Diego Rosales Ruiz, Flor Beltran Valdivia, Claudia Mori Torres, Vanessa Valenzuela Granados, Flor Araujo León, Cecilia Cabrera Cabrejos, ... María Grazia Venturelli Romero

Ann Hepatol. 2021;24 Supl 1:100366.105

Open access

P-112 ALPHA-FETOPROTEIN AS A PROGNOSTIC FACTOR IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO LIVER TRANSPLANTATION – BRAZILIAN MULTICENTER STUDY

Aline Lopes Chagas, Ângelo Alves de Mattos, Márcio Augusto Diniz, Guilherme Eduardo Gonçalves Felga, Ilka de Fátima Santana Ferreira Boin, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, José Huygens Parente Garcia, ... Brazilian HCC Study Group

Ann Hepatol. 2021;24 Supl 1:100366.106

Open access

P-113 COVID 19 AND CIRRHOSIS, A DEADLY COMBINATION. WHAT HAPPENS IN ECUADOR?

Manuel Guaranda, Maizury Garzón, Rubén Muñoz, Diana Carbonell, Marcela Mahecha

Ann Hepatol. 2021;24 Supl 1:100366.107

Open access

P-114 LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: OUTCOMES IN THE MAIN TRANSPLANT CENTER IN PERU

Saúl Espinoza, Martin Padilla, Julia Sumire, Bertha Cárdenas, Carmen Cerrón, Omar Mantilla, Jose Rivera, Alfonso Solar, ... Carlos Rondon

Ann Hepatol. 2021;24 Supl 1:100366.108

Open access

P-115 MANAGEMENT AND OUTCOME OF LIVER ABCESS AFTER LIVER TRANSPLANTATION: EXPERIENCE OF A SINGLE CENTER IN PERU

Augudberto Montufar, Carlos Rondón, Bacilio Wilmer, Omar Mantilla, José Rivera, Alfonso Solar, Bertha Cárdenas, Carmen Cerrón, ... Martin Padilla

Ann Hepatol. 2021;24 Supl 1:100366.109

Open access

P-116 PREGNANCY AFTER LIVER TRANSPLANTATION: OUTCOMES IN PERU

Bertha Cárdenas Ramírez, Martin Padilla-Machaca P., Omar Mantilla Cruzatti, José Rivera Romaní, Alfonso Solar Peche, Carmen Cerrón Cabezas, Saul Espinoza Rivera, Augudberto Montufar Valer, ... Carlos Rondón Leyva

Ann Hepatol. 2021;24 Supl 1:100366.110

Open access

P-117 LOW PREVALENCE OF HEPATITIS B AND C AMONG PEOPLE LIVING IN POVERTY IN NORTHEAST BRAZIL

Livia Melo Villar, Aline Borges Cardoso, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, Barbara Vieira do Lago

Ann Hepatol. 2021;24 Supl 1:100366.111

Open access

P-118 NONINVASIVE PARAMETERS OF PREDICTORS OF ESOPHAGEAL VARICES (EV) IN CHILDREN WITH INTRAHEPATIC PORTAL HYPERTENSION

Marina R. Adam, Carlos Oscar Kieling, Guedes Renata Rostirola, Sandra MG Vieira

Ann Hepatol. 2021;24 Supl 1:100366.112

Open access

P-119 GENETIC VARIABILITY OF HEPATITIS B VIRUS AMONG DIFFERENT PHASES OF CHRONIC INFECTION AND HIV COINFECTION IN BRAZIL

Livia Melo Villar, Bianca Leires Marques, Larissa Tropiano da Silva Andrade, Vanessa Alves Marques, Moyra Machado Portilho, Lia Laura Lewis-Ximenez, Barbara Vieira do Lago

Ann Hepatol. 2021;24 Supl 1:100366.113

Open access

P-120 NATIONAL SURVEY ON CURRENT PRACTICES TO PREVENT HBV REACTIVATION DURING IMMUNOSUPPRESSION

J.M. Araujo-Neto, M. Iasi, L.C. Nabuco, F.S.R.P. Pessoa, E. Vilela, R. Stucchi, L.Y. Sassaki, A.K.G. Melo, ... C.E. Brandão

Ann Hepatol. 2021;24 Supl 1:100366.114

Open access

P-121 ASSESSMENT OF THE ANTERIOR AND POSTERIOR ATTENTIONAL NETWORKS IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY

Daniel Santana, Luis Pérez José, Fátima Higuera de la Tijera

Ann Hepatol. 2021;24 Supl 1:100366.115

Open access

P-122 LIVER TRANSIENT ELASTOGRAPHY (FIBROSCAN). FIRST REPORT OF EXPERIENCE IN ECUADOR

Jaysoom Abarca Ruiz, Mariela Villagomez Estrada, Wendy Calderón, Enrique Carrera

Ann Hepatol. 2021;24 Supl 1:100366.116

Open access

P-123 PROFILE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) X TREATMENT: A NUTROLOGY'S VIEW

Suzana Tyrrasch de Almeida-PHD, Georges Benedicto de Almeida Neto, Ana Paula Tyrrasch de Almeida, Felipe Gabino Macedo

Ann Hepatol. 2021;24 Supl 1:100366.117

Open access

P-124 POST PARACENTESIS COMPLICATIONS IN PATIENTS WITH DIAGNOSIS OF LIVER CIRRHOSIS

Kevin Molina

Ann Hepatol. 2021;24 Supl 1:100366.118

Open access

P-125 REX SHUNT IN A DEVELOPING COUNTRY – IS IT POSSIBLE?

Caroline Montagner Dias, Melina Utz Melere, Carolina Soares da Silva, Luiza Salgado Nader, Cristine Suzana Trein, Alex Finger Horbe, Cristina Targa Ferreira, Riccardo Superina

Ann Hepatol. 2021;24 Supl 1:100366.119

Open access

P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID?

Felipe Ramírez, Alvaro Urzúa, Máximo Cattaneo, Pablo Roblero Juan, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1:100366.120

Open access

P-127 HEPATITIS A WITH ACALCULOUS CHOLECYSTITIS, PLEURAL EFFUSION, PERICARDIAL EFFUSION AND ASCITIS

Aileen Mateo, Eliam Rivas

Ann Hepatol. 2021;24 Supl 1:100366.121

Open access

O-1 THE ROLE OF PNPLA3 AND TM6SF2 POLYMORPHISMS ON LIVER FIBROSIS AND METABOLIC ABNORMALITIES IN BRAZILIAN PATIENTS WITH CHRONIC HEPATITIS C

Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, ... Daniel F. Mazo

Ann Hepatol. 2021;24 Supl 1:100366.122

Open access

O-2 ROLE OF IMMUNE CHECKPOINTS AND ACTIVATED HELPER AND CYTOTOXIC T-CELLS IN DRUG-INDUCED LIVER INJURY (DILI)

Alejandro Cueto-Sanchez, Judith Sanabria Cabrera, Mercedes Robles-Diaz, Aida Ortega-Alonso, Miren Garcia Cortes, Enrique del Campo-Herrera, Rocio Gonzalez-Grande, Miguel Jimenez-Perez, ... Raúl J Andrade

Ann Hepatol. 2021;24 Supl 1:100366.123

Open access

O-3 TRENDS IN DECEASED DONOR AND LIVING DONOR LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES DURING A DECADE (2010-2019) . THE ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2020

Rodrigo Zapata, Graciela Castro, Josefina Pages, Cairo Fernando, Oscar Imventarza, Alejandra Villamil, Paulo Bittencourt, Leonardo Schiavon, ... Solange Gerona

Ann Hepatol. 2021;24 Supl 1:100366.124

Open access

O-4 IMPACT OF BRIDGE THERAPY FOR HEPATOCELLULAR CARCINOMA IN PATIENTS SUBMITTED TO LIVER TRANSPLANTATION - BRAZILIAN MULTICENTER STUDY

Julia Fadini Margon, Aline Lopes Chagas, Angelo A. Mattos, Márcio Augusto Diniz, Guilherme Eduardo Gonçalves Felga, Ilka de Fátima Santana Ferreira Boin, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, ... Brazilian HCC Study Group

Ann Hepatol. 2021;24 Supl 1:100366.125

Open access

O-5 PROGNOSTIC IMPORTANCE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN®) FOR MORTALITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES

Nathalie C. Leite, Cristiane A. Villela-Nogueira, Claudia R.L. Cardoso, Gil F. Salles

Ann Hepatol. 2021;24 Supl 1:100366.126

Open access

O-6 NON-INVASIVE ASSESSMENT OS HEPATIC FIBROSIS BEFORE AND AFTER HCV CURE AND CORRELATION WITH CLINICAL OUTCOMES

T.G. Ragazzo, G. Garcia-Tsao, D.F. Mazo, P.M. Ziteli, C.P. Oliveira, J.M. Singer, F.J. Carrilho, M.G. Pessoa

Ann Hepatol. 2021;24 Supl 1:100366.127

Open access

O-7 PREVALENCE, CHARACTERIZATION AND SURVIVAL OF ACUTE-ON-CHRONIC LIVER FAILURE IN A CHILEAN UNIVERSITY HOSPITAL

Francisco Idalsoaga, Francisco Valenzuela, Antonio Díaz Luis, Franco Manzur, Victor Meza, Joaquin Sotomayor, Maximiliano Schalper, Franco Chianale, ... Juan Arab Pablo

Ann Hepatol. 2021;24 Supl 1:100366.128

Open access

O-8 THE IMPORTANCE OF LYSOSOMAL ACID LIPASE DEFICIENCY IN THE ETIOLOGICAL INVESTIGATION OF CRYPTOGENIC LIVER DISEASE IN ADULTS: A MULTICENTER STUDY

Aline Coelho Rocha Candolo, Patricia Momoyo Zitelli, Daniel Ferraz de Campos Mazo, Marlone Cunha-Silva, Raquel Dias Greca, Claudia Pinto de Oliveira, Roberta Chaves Araújo, Amanda Sacha Paulino Tolentino Alustau, ... Mário Guimarães Pessoa

Ann Hepatol. 2021;24 Supl 1:100366.129

Open access

O-9 COMPARISON OF THE PERFORMANCE OF DIFFERENT SCORES FOR THE PREDICTION OF IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS

Agustina Martinez Garmendia, Maria Nelly Gutierrez Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, Jose Luis Fernandez, Maria Margarita Anders, Nadia Grigera, ... Sebastián Marciano

Ann Hepatol. 2021;24 Supl 1:100366.130

Open access

O-10 PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BY DIFFERENT COMBINATIONS OF THE DIAGNOSTIC CRITERIA PRESENT CLINICAL AND LABORATORY PECULIARITIES

Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria

Ann Hepatol. 2021;24 Supl 1:100366.131

Open access

O-11 REMODELING OF IMMUNOLOGICAL BIOMARKERS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECTACTING ANTIVIRAL THERAPY

Isabela Gomes Ribeiro, Jordana Grazziela Alves Coelho-Dos-Reis, Jordana Rodrigues Barbosa Fradico, Ismael Artur da Costa-Rocha, Luciana Diniz Silva, Lucy Ana Santos Fonseca, Rhaissa Carvalho Said Stancioli, Andréa Teixeira-Carvalho, ... Rosângela Teixeira

Ann Hepatol. 2021;24 Supl 1:100366.132

Open access

O-12 MIR-181A AS A BIOMARKER OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE

Rodrigo Vieira Costa Lima, Fernanda de Mello Malta, José Tadeu Stefano, João Renato Pinho, Flair José Carrilho, Claudia Pinto Marques Souza de Oliveira

Ann Hepatol. 2021;24 Supl 1:100366.133

Open access

O-13 Hepatocellular carcinoma patients are advantage in the Brazilian current liver transplant allocation system. A competing risk analysis. A RETROSPECTIVE STUDY

Santiago Rodrıguez, Alfeu de Medeiros Fleck, Marcos Mucenic, Claudio Marroni, Ajacio Brandão

Ann Hepatol. 2021;24 Supl 1:100366.134

Open access

O-14 A SYNERGISTIC EFFECT OF PNPLA3 GENE POLYMORPHISM AND INSULIN RESISTANCE INCREASES THE RISK TO NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Amanda Recuero, Fernanda Malta, Larissa Gomes, Gustavo Maciel, Paula Salles Ana, Sandra Tochetto, Maria Cristina Chammas, Denise Paranaguá-Vezozzo, ... Oliveira Claudia P.

Ann Hepatol. 2021;24 Supl 1:100366.135

Open access

O-15 ABSENCE OF DISEASE REMISSION AS A RISK FACTOR FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH AUTOIMMUNE HEPATITIS

Nayana Fonseca Vaz, Julia Fadini Margon, Bruna Damasio Moutinho, Michele Harriz Braga, Claudia Megumi Tani, Regiane Saraiva de Souza Melo Alengar, Lisa Rodrigues da Cunha Saud, Denise Cerqueira Paranaguá Vezozzo, ... Débora Terrabuio

Ann Hepatol. 2021;24 Supl 1:100366.136

Open access

O-16 EVALUATION OF THE RESPONSE TO TREATMENT OF VITAMIN D DEFICIENCY IN PEDIATRIC PATIENTS WITH CHRONIC LIVER DISEASE

Carolina Roos Mariano da Rocha, Carlos Oscar Kieling, Marina Rossato Adami, Renata Rostirola Guedes, Guilherme Guaragna Filho, Sandra Maria Gonçalves Vieira

Ann Hepatol. 2021;24 Supl 1:100366.137

Open access

O-17 Are macroeconomic and health expenditure indicators correlated with the capacity for liver transplantation in Latin American Countries? THE ALEH Special Interest Group, international Survey 2020

Rodrigo Zapata, Graciela Castro, Josefina Pages, Fernando Cairo, Oscar Imventarza, Alejandra Villamil, Paulo Bittencourt, Leonardo Schiavon, ... Solange Gerona

Ann Hepatol. 2021;24 Supl 1:100366.138

Open access

O-18 IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-CIRRHOTIC CHRONIC HCV PATIENTS IS NOT OVERCOME BY DOUBLE DOSE REGIMEN. FOURTH DOSE MAYBE THE ANSWER!

Roseane Pôrto Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer L. Dodge, Patricia M. Zitelli, M. Lopes, Flair J. Carrilho, Mário Guimarães Pessoa

Ann Hepatol. 2021;24 Supl 1:100366.139

Open access

O-19 INCIDENCE, PATTERN OF PRESENTATION AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AFTER DIRECT ACTING ANTIVIRAL TREATMENT IN PATIENTS WITH HEPATITIS C VIRUS CIRRHOSIS

Roseane Porto Medeiros, Oscar Imventarza, Alejandra Villamil, Pablo Bittencourt, Leonardo Schiavon, Alfeu de Medeiros Fleck, Ricardo Villarroel, Oscar Varas, ... Adriana Varón

Ann Hepatol. 2021;24 Supl 1:100366.140

Open access

O-20 ASSOCIATION BETWEEN UNCOUPLING PROTEIN 3 POLYMORPHISMS AND NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME

Karla Toda-Oti, José Tadeu Stefano, Ana Cavaleiro, Flair Carrilho, Maria Lúcia Correa-Gianella, Cláudia Oliveira

Ann Hepatol. 2021;24 Supl 1:100366.141

Open access

O-21 SOLUBLE CD163 PERFORMANCE AS A NON-INVASIVE BIOMARKER OF DIFFERENT LIVER CONDITIONS

Cairoli Victoria, Casciato Paola Cecilia, Giadans Cecilia Graciela, Ameigeiras Beatriz, De Matteo Elena, Preciado Maria Victoria, Valva Pamela

Ann Hepatol. 2021;24 Supl 1:100366.142

Open access

O-22 METABOLIC ASSOCIATED FATTY LIVER DISEASE: A SEVERE LIVER DISEASE

Ana Rafaela S. Do Vale, Andreza Rosa Cabral, Naiade S. Almeida, Antonio Ricardo C.F. Andrade, Ana Cristina Landim, Helma P. Cotrim

Ann Hepatol. 2021;24 Supl 1:100366.143

Open access

O-23 METABOLIC ASSOCIATED FATTY LIVER DISEASE CLINICAL PROFILE IN LEAN PATIENTS: CAN IT BE DIFFERENT?

Andreza Rosa Cabral, Ana Rafaela S. Do Vale, Naiades S. Almeida, Raquel Rocha, Antonio Ricardo C.F. de Andrade, Ana Cristina Landin, Helma P. Cotrim

Ann Hepatol. 2021;24 Supl 1:100366.144

Open access

O-24 A CASE SERIES OF CHLOROQUINE MONOTHERAPY TO INDUCE BIOCHEMICAL REMISSION IN PATIENTS WITH RELAPSED AUTOIMMUNE HEPATITIS

Bianca Pocopetz Facas, Júlia Fadini Margon, Andreia Silva Evangelista, Amanda Rodrigues de Moreto Longo Galvão, Eduardo Cançado, Débora Raquel Benedita Terrabuio

Ann Hepatol. 2021;24 Supl 1:100366.145

Open access

O-25 BACTERIAL INFECTION ENHANCES THROMBIN GENERATION IN PATIENTS WITH CIRRHOSIS

Marina Pamponet Motta, Elbio Antonio D'Antonio D'Amico, Tânia Rubia Flores da Rocha, Beatriz Yuri Migita, Juliana Medeiros Batista, Caroline Marcondes Ferreira, Flair José Carrilho, Alberto Queiroz Farias

Ann Hepatol. 2021;24 Supl 1:100366.146

Open access

O-26 ASPARTATE AMINOTRANSFERASE, AGE AND D-DIMER IN COVID-19 PATIENTS: A USEFUL PROGNOSTIC MODEL

Fátima Higuera-de la Tijera, Alfredo Servín-Caamaño, Daniel Reyes-Herrera, Argelia Flores-López, Enrique J.A. Robiou-Vivero, Felipe Martínez-Rivera, Victor Galindo-Hernández, Catalina Casillas-Suárez, ... José Luis Pérez-Hernández

Ann Hepatol. 2021;24 Supl 1:100366.147

Open access

O-27 IMPACT OF HBV GENOTYPE F IN THE DIAGNOSIS AND EVOLUTION OF PATIENTS WITH HBEAG-NEGATIVE CHRONIC HBV INFECTION

Hugo Fainboim, Nicolas Dibenedeto, Paz Silvia, Mendizabal Manuel, Soledad Campuzano, Micaela Martinez, Luciana Tadey, Gabriel Deluchi, ... Diego Flichman

Ann Hepatol. 2021;24 Supl 1:100366.148

Open access

O-28 DRUG-INDUCED LIVER INJURY IN LATINAMERICA: First ten years’ experience of the ongoing LATINDILI Network

Fernando Bessone, Nelia Hernandez, Raymundo Parana, Manuel Mendizabal, Adriana Sanchez, Vinicius Nunes, Ezequiel Ridruejo, Daniela Schiodi, ... Andrade Raul J.

Ann Hepatol. 2021;24 Supl 1:100366.149

Open access

OP-1 GUT METATRANSCRIPTOMICS AND METABOLOMICS REVEAL ASSOCIATION OF CYSTEINE AND PURINE METABOLISMS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD)

Noelia Mazzini Flavia, Florencia Mascardi María, Ruda Vera M., Shilpa Pandit, Leandra Mansur, Yanqun Wang, Gounarides John, Cook Frank, ... Julieta Trinks

Ann Hepatol. 2021;24 Supl 1:100366.150

Open access

OP-2 IN VITRO CHARACTERIZATION OF HEPATITIS B VIRUS REPLICATION AND VIRAL ANTIGEN EXPRESSION AMONG GENOTYPES

Mercedes Elizalde, Micaela Martinez, Micaela Speroni, Luciana Tadey, Mammana Lilia, Bouzas Belen, Mojsiejczuk Laura, Campos Rodolfo, Diego Flichman

Ann Hepatol. 2021;24 Supl 1:100366.151

Open access

OP-3 LONG-TERM RIFAXIMIN IS SAFE AND ITS RELATED TO LESS FREQUENCY OF COMPLICATIONS LIKE VARICEAL BLEEDING IN CIRRHOTIC PATIENTS

Fátima Higuera-de-la-Tijera, Karen Soto-Martínez, Victor H. Fúnez-Madrid, José L. Pérez-Hernández, Graciela Alexanderson-Rosas, Alfredo Servín Caamaño

Ann Hepatol. 2021;24 Supl 1:100366.152

Open access

OP-4 Current status of Liver transplantation in Latin America: The Latin-American ALEH special interest group, international Survey 2020

Rodrigo Zapata, Graciela Castro, Josefina Pages, Fernando Cairo, Oscar Imventarza, Alejandra Villamil, Paulo Bittencourt, Leonardo Schiavon, ... Solange Gerona

Ann Hepatol. 2021;24 Supl 1:100366.153

Open access

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter